Claire Thorne

Author PubWeight™ 63.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS 2014 2.67
2 Response to combination antiretroviral therapy: variation by age. AIDS 2008 2.28
3 Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet 2011 1.90
4 Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis 2007 1.88
5 Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res 2007 1.85
6 CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis 2006 1.46
7 Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr 2005 1.32
8 Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol 2006 1.16
9 Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIV-uninfected mothers in rural South Africa. Antivir Ther 2012 1.13
10 Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Arch Intern Med 2010 1.12
11 Reproductive experience of HIV-infected women living in Europe. Hum Reprod 2008 1.12
12 Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod 2012 1.12
13 Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 2004 1.10
14 Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS 2005 1.08
15 Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health 2006 1.08
16 Increasing likelihood of further live births in HIV-infected women in recent years. BJOG 2005 1.05
17 Pregnancy and HIV infection: A european consensus on management. AIDS 2002 1.04
18 Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda. Ann Trop Paediatr 2006 1.03
19 Tuberculosis and HIV co-infection in children. BMC Infect Dis 2014 1.00
20 Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol 2007 0.99
21 Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network. J Pediatr Gastroenterol Nutr 2009 0.97
22 Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990-2009. J Acquir Immune Defic Syndr 2012 0.96
23 Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr 2005 0.96
24 National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ? Eur J Public Health 2013 0.95
25 Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr 2011 0.94
26 Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors. J Acquir Immune Defic Syndr 2012 0.94
27 Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther 2011 0.92
28 Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care. AIDS 2013 0.92
29 Cell-free (RNA) and cell-associated (DNA) HIV-1 and postnatal transmission through breastfeeding. PLoS One 2012 0.91
30 Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS 2013 0.90
31 Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis 2007 0.89
32 Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2003 0.89
33 Pregnancies in young women with vertically acquired HIV infection in Europe. AIDS 2007 0.89
34 Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine. Bull World Health Organ 2013 0.89
35 Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine. BMC Pediatr 2010 0.88
36 Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine. PLoS One 2012 0.88
37 Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clin Infect Dis 2011 0.87
38 Mother-to-child transmission risk is increased among HIV-infected pregnant women in Ukraine with serological test results positive for syphilis. Clin Infect Dis 2008 0.87
39 Post-licensing safety of fosamprenavir in HIV-infected children in Europe. Pharmacoepidemiol Drug Saf 2014 0.86
40 Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe. Clin Infect Dis 2009 0.86
41 Vertically acquired paediatric coinfection with HIV and hepatitis C virus. Lancet Infect Dis 2006 0.85
42 Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy? AIDS 2014 0.84
43 Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIV-positive women. BMC Med Res Methodol 2012 0.84
44 Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery. J Acquir Immune Defic Syndr 2013 0.84
45 Antiretroviral therapy and mother-to-child transmission of HIV-1. Expert Rev Anti Infect Ther 2004 0.84
46 Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health 2014 0.83
47 Factors associated with abandonment of infants born to HIV-positive women: results from a Ukrainian birth cohort. AIDS Care 2010 0.83
48 Prenatal diagnosis in human immunodeficiency virus-infected women: a new screening program for chromosomal anomalies. Am J Obstet Gynecol 2006 0.82
49 Current guidelines on management of HIV-infected pregnant women: impact on mode of delivery. Eur J Obstet Gynecol Reprod Biol 2008 0.82
50 Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception. AIDS 2011 0.82
51 Levels and patterns of HIV RNA viral load in untreated pregnant women. Int J Infect Dis 2008 0.81
52 The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy. AIDS 2015 0.81
53 Management of hepatitis B in pregnant women and infants: a multicentre audit from four London hospitals. BMC Pregnancy Childbirth 2013 0.78
54 The new face of the pediatric HIV epidemic in Western countries: demographic characteristics, morbidity and mortality of the pediatric HIV-infected population. Pediatr Infect Dis J 2015 0.77
55 Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women. Antivir Ther 2012 0.77
56 Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers. Curr Opin HIV AIDS 2016 0.77
57 Improvements in virological control among women conceiving on combination antiretroviral therapy in Western Europe. AIDS 2013 0.77
58 European participation in an international perinatal trial. Med Wieku Rozwoj 2004 0.77
59 Policies and practices for the clinical management of HIV/HCV coinfected children in Europe: an epidemiological survey. Eur J Pediatr 2008 0.76
60 Breastfeeding and transmission of viruses other than HIV-1. Adv Exp Med Biol 2012 0.76
61 Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy. AIDS 2015 0.76
62 A new piece in the puzzle of antiretroviral therapy in pregnancy and preterm delivery risk. Clin Infect Dis 2012 0.75
63 Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy. Pediatr Infect Dis J 2017 0.75
64 A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model. Epidemiology 2016 0.75
65 Hepatitis C Co-Infection and CD4+ T Cell Recovery in HIV-Infected Children Receiving Anti-Retroviral Therapy. Pediatr Infect Dis J 2016 0.75
66 Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'. AIDS 2007 0.75
67 Response to antiretroviral therapy (ART): comparing women with previous use of zidovudine monotherapy (ZDVm) in pregnancy with ART naïve women. BMC Infect Dis 2014 0.75
68 HIV and HCV progression in parenterally coinfected children. Curr HIV Res 2009 0.75
69 The Challenge of Treating Children with Hepatitis C Virus Infection. J Pediatr Gastroenterol Nutr 2017 0.75
70 Pregnancy incidence and outcomes in women with perinatal HIV infection. AIDS 2017 0.75
71 Syphilis, hepatitis C and HIV in Eastern Europe. Curr Opin Infect Dis 2016 0.75